The efficacy and safety of low-dose naltrexone in the treatment of lichen planopilaris and frontal fibrosing alopecia: A systematic review.

J Am Acad Dermatol

Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada; Donovan Hair Clinic, Whistler, BC, Canada. Electronic address:

Published: September 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2025.08.076DOI Listing

Publication Analysis

Top Keywords

efficacy safety
4
safety low-dose
4
low-dose naltrexone
4
naltrexone treatment
4
treatment lichen
4
lichen planopilaris
4
planopilaris frontal
4
frontal fibrosing
4
fibrosing alopecia
4
alopecia systematic
4

Similar Publications

Background: To review the biological functions of ergothioneine (ERGO), its correlation with plasma levels in cognitive frailty, and research progress in treating frailty and cognitive impairment, with the aim of providing a reference for ERGO application in cognitive frailty treatment.

Methods: A comprehensive review of existing literature on ERGO's chemical structure, sources, antioxidant and anti-inflammatory effects, and its role in cognitive frailty was conducted. Clinical trial data and metabolomic studies were also analyzed to understand ERGO's therapeutic potential.

View Article and Find Full Text PDF

Background: Endometriosis symptoms have multifaceted manifestations, and there are few approved nonsurgical treatment options. Gonadotropin-releasing hormone (GnRH) agonists/antagonists for endometriosis vary on efficacy, safety profile, and out-of-pocket (OOP) cost, among other features.

Objectives: This study quantified the importance that women with endometriosis in the United States (US) placed on pain and non-pain features that differ among these medications.

View Article and Find Full Text PDF

Early intervention in impending myasthenic crisis (IMC) is critical to avert life-threatening progression. This study compared the clinical effectiveness and safety of the novel FcRn antagonist efgartigimod versus intravenous immunoglobulin (IVIg) in IMC management. In this retrospective cohort study, we analyzed 51 acetylcholine receptor antibody-positive (AChR-Ab+) IMC patients who received either efgartigimod (n ​= ​30) or IVIg (n ​= ​21) from June 2023 to November 2024.

View Article and Find Full Text PDF

Objective: This study evaluates the safety and efficacy of single-port versus multi-port laparoscopic surgery in pediatric inguinal hernia repair through a systematic review and meta-analysis.

Methods: Following PRISMA guidelines, a comprehensive literature search was conducted up to December 2024. Studies comparing single-port and multi-port laparoscopic surgery in pediatric inguinal hernia patients were included.

View Article and Find Full Text PDF